Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

780.67
+1.390.18%
Post-market: 780.00-0.6700-0.09%16:58 EDT
Volume:1.45M
Turnover:1.13B
Market Cap:739.87B
PE:66.67
High:783.55
Open:780.46
Low:773.00
Close:779.28
Loading ...

Eli Lilly (LLY) Raises Dividend for 11th Consecutive Year

TIPRANKS
·
26 Jun

Eli Lilly - FDA Approves Updated Label for Lilly’s Amyvid (Florbetapir F 18 Injection) to Support Diagnosis of Alzheimer’s Disease in Patients

THOMSON REUTERS
·
26 Jun

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Sana Biotechnology (SANA)

TIPRANKS
·
26 Jun

Eli Lilly’s Promising Alzheimer’s Study: A Potential Game-Changer?

TIPRANKS
·
26 Jun

EXCLUSIVE-New data show most US patients now stay on Wegovy, Zepbound after a year

Reuters
·
25 Jun

Citi sees tiered orforglipron pricing $15B opportunity for Eli Lilly

TIPRANKS
·
25 Jun

3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow

Motley Fool
·
25 Jun

Exclusive-Nearly Two-Thirds of US Patients Taking Wegovy or Zepbound Stayed on the Drug in Past Year, New Data Show

THOMSON REUTERS
·
25 Jun

After key conference, here's how the race to a $150 billion weight-loss drug market is shaping up

Dow Jones
·
25 Jun

Eli Lilly treatment of KRAS G12C-mutant NSCLC granted orphan designation

TIPRANKS
·
25 Jun

Health Rounds: Inhaled insulin as good as injection for children at mealtime

Reuters
·
25 Jun

Eli Lilly’s LY3971297 Study: A Potential Game-Changer in Drug Safety Evaluation

TIPRANKS
·
25 Jun

Eli Lilly’s Promising Clinical Trials Reinforce Buy Rating

TIPRANKS
·
24 Jun

Novo Nordisk launches weight-loss drug Wegovy in India to compete with Lilly's Mounjaro

Reuters
·
24 Jun

Best CEOs: Dave Ricks -- Barron's

Dow Jones
·
24 Jun

Weight-Loss Drug Propels Eli Lilly Stock (LLY) Towards Record High

TIPRANKS
·
24 Jun

Morgan Stanley Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
24 Jun

Evercore ISI Sticks to Its Hold Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
24 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, Eli Lilly, Nuclear stocks

Reuters
·
23 Jun

Eli Lilly Keeps Quarterly Dividend at $1.50 a Share, Payable Sept. 10 to Shareholders of Record as of Aug. 15

MT Newswires Live
·
23 Jun